Get the Stockscreener App
18.90
0.53%
0.10
Clearpoint Neuro Inc Stock (CLPT) Latest News
ClearPoint Neuro (NASDAQ:CLPT) Trading 8.5% HigherShould You Buy? - MarketBeat
JPMorgan Chase & Co. Has $110,000 Holdings in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
CLPT Stock Gains on FDA Clearance for Navigation Software Version 3.0 - MSN
B. Riley Boosts ClearPoint Neuro (NASDAQ:CLPT) Price Target to $20.00 - MarketBeat
Stifel maintains Clearpoint Neuro stock Buy rating, $17 target - MSN
B. Riley Raises ClearPoint Neuro (NASDAQ:CLPT) Price Target to $20.00 - Defense World
How to Take Advantage of moves in (CLPT) - Stock Traders Daily
Stifel maintains Clearpoint Neuro stock Buy rating, $17 target By Investing.com - Investing.com UK
ClearPoint Neuro price target raised to $20 from $15 at B. Riley - Yahoo Finance
ClearPoint Neuro, Inc. (CLPT): A Bull Case Theory - Insider Monkey
B. Riley Raises Price Target on ClearPoint Neuro to $20 From $15, Keeps Buy Rating - Marketscreener.com
ClearPoint Neuro gains FDA clearance for software - MSN
ClearPoint Neuro Secures FDA Clearance for Revolutionary CT Navigation Software - StockTitan
Barclays PLC Raises Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
Conway Capital Management Inc. Boosts Stock Holdings in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat
ClearPoint Neuro (CLPT) Surges 22.5%: Is This an Indication of Further Gains? - MSN
CLPT Stock Touches 52-Week High at $17.49 Amidst Strong Yearly Growth - MSN
Lake Street Capital Issues Positive Forecast for ClearPoint Neuro (NASDAQ:CLPT) Stock Price - Defense World
ClearPoint Neuro (NASDAQ:CLPT) Sets New 12-Month High After Analyst Upgrade - Defense World
Clearpoint Neuro stock target lifted, buy rating on robust performance By Investing.com - Investing.com Canada
ClearPoint Neuro Reports Third Quarter 2024 Results - ACCESS Newswire
ClearPoint Neuro (NASDAQ:CLPT) Reaches New 1-Year High on Analyst Upgrade - MarketBeat
Clearpoint Neuro stock target lifted, buy rating on robust performance - MSN
Barclays PLC Boosts Stock Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
Trend Tracker for (CLPT) - Stock Traders Daily
Geode Capital Management LLC Buys 4,170 Shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
Here's What Could Help ClearPoint Neuro (CLPT) Maintain Its Recent Price Strength - MSN
State Street Corp Has $1.18 Million Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
Jane Street Group LLC Has $1.14 Million Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Shares Sold by Jane Street Group LLC - MarketBeat
Long Term Trading Analysis for (CLPT) - Stock Traders Daily
OU Health adds technology for deep brain stimulation procedures - Norman Transcript
Conway Capital Management Inc. Takes Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat
After Leaping 26% ClearPoint Neuro, Inc. (NASDAQ:CLPT) Shares Are Not Flying Under The Radar - Simply Wall St
ClearPoint: Fundamentals Continue To Improve (NASDAQ:CLPT) - Seeking Alpha
(CLPT) Proactive Strategies - Stock Traders Daily
(CLPT) Technical Pivots with Risk Controls - Stock Traders Daily
ClearPoint Neuro Inc (CLPT) Trading 3.92% Higher on Oct 9 - GuruFocus.com
Pekin Hardy Strauss Inc. Invests $541,000 in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat
Oppenheimer & Co. Inc. Takes Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
West Pharmaceutical Services (NYSE:WST) & ClearPoint Neuro (NASDAQ:CLPT) Critical Comparison - Defense World
Global MRI Guided Neurosurgical Ablation Market Poised for Steady Growth, Projected to Reach USD 227.56 Million by 2034 Driven by Growing Adoption and Advancements in Non-Cooled Laser Systems: FMI - GlobeNewswire Inc.
(CLPT) Investment Analysis - Stock Traders Daily
5.14%
2.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):